Stay updated on Nivolumab in Relapsed/Refractory DLBCL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Added an expanded Locations section listing study sites by region and country (e.g., multiple U.S. states and international locations) and updated the page revision to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T08:38:37.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:21:59.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added a note that PubMed publications are automatically filled from PubMed and may not be about the study, and updated the revision label to v3.3.1. Removed the older PubMed-origin description and the v3.2.0 revision reference.
    Difference
    0.1%
    Check dated 2025-11-24T14:35:01.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The funding/operating-status notice previously displayed on the page has been removed.
    Difference
    0.3%
    Check dated 2025-11-17T06:52:59.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    No substantive changes to core study information were detected; any updates appear to be formatting or metadata adjustments rather than content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:19:15.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Update includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.
    Difference
    3%
    Check dated 2025-10-05T10:10:45.000Z thumbnail image

Stay in the know with updates to Nivolumab in Relapsed/Refractory DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page.